Hunt for AIDS cure accelerates as GSK and U.S. experts link up

LONDON (Reuters) - Britain's GlaxoSmithKline, which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS.Read more...